Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
JACC Case Rep ; 29(14): 102410, 2024 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-39006409

RESUMEN

We report a case of infective endocarditis with a septal abscess that was complicated with abnormal blood flow from the left ventricle to the right atrium (Gerbode defect) along with abnormal blood flow from the aorta to the right atrium (atrial-aortic fistula). This is the first reported case of successful correction of both defects by a percutaneous approach.

2.
J Invasive Cardiol ; 25(4): E81-6, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23549503

RESUMEN

BACKGROUND: Von Willebrand disease (vWD) results from quantitative or qualitative deficiency of von Willebrand factor (vWF). The occurrence of myocardial infarction is very rare in patients with vWD. A few case reports of acute coronary syndrome (ACS) in vWD patients are present in the literature, but no definite management recommendations are available for such patients. CASE REPORT: We report a case of successful percutaneous coronary intervention (PCI) with bare-metal stent (BMS) implantation in a 46-year-old woman with type 1 vWD and history of coronary artery disease (CAD). She received periprocedural dual-antiplatelet therapy for 2 weeks and then continued aspirin without any bleeding complications. MANAGEMENT PROPOSAL: The optimal management of patients with vWD and ACS is complex and presents a therapeutic challenge. We propose that dual-antiplatelet therapy can be used safely in most vWD patients presenting with ACS as most of them are type 1 vWD. PCI with BMS can be done safely. Long-term management of these patients requires a systemic approach including hematological consultation, ascertaining vWF levels, as well as patient education and close outpatient follow-up.


Asunto(s)
Síndrome Coronario Agudo/epidemiología , Síndrome Coronario Agudo/terapia , Manejo de la Enfermedad , Intervención Coronaria Percutánea/métodos , Enfermedades de von Willebrand/epidemiología , Comorbilidad , Quimioterapia Combinada , Femenino , Fibrinolíticos/uso terapéutico , Humanos , Persona de Mediana Edad , Educación del Paciente como Asunto , Inhibidores de Agregación Plaquetaria/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA